‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.

Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.

Patients put at risk as crisis hits supplies of vital antibiotics, HRT and anti-depressants. / Vital antibiotics, hormone replacement therapy (HRT) and attention deficit hyperactivity disorder (ADHD) drugs are among those in desperately short supply this winter – with the NHS forced to pay over the odds to get drugs into Britain.

The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.

Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.

Hundreds of researchers and organisations across Europe have called for the rapid association of the UK and Switzerland to Horizon Europe.

This being 2020, it didn't take long for good news about the Pfizer/BioNTech jab to turn into a tiresome row about Brexit.

The government has announced the plans – but hasn't decided what form of transport will be used.